Enterprise AIConfidence BUnited Statesactive

Xaira Therapeutics

AI drug discovery company combining machine learning, biology, and therapeutic development.

Official websitexaira.com
RegionBrisbane, United States
CategoryEnterprise AI
Funding statusSeries A · Undisclosed
Last updatedJun 11, 2026
Latest signalJun 11, 2026

Status timeline

Funding, product, customer, team, and correction signals
Apr 23, 2024Confidence A
Product0 evidence links

Xaira Therapeutics product scope reviewed

Xaira Therapeutics public product source reviewed for category placement and current operating focus.

No source evidence matched to this event.
Apr 23, 2024Confidence A
Funding0 evidence links

Xaira Therapeutics capital or status signal reviewed

Xaira Therapeutics public source reviewed for capital or strategic-status timeline signal.

No source evidence matched to this event.

Funding timeline

Amounts are shown only when disclosed and tied to evidence.
Apr 23, 2024

Series A

AmountUndisclosed
InvestorsARCH Venture Partners, Foresite Labs
EvidenceConfidence A
No source evidence matched to this round.

Source evidence

Public links, short factual summaries, and trust levels

Xaira Therapeutics capital or status signal

Xaira Therapeutics · official
Confidence A

Xaira Therapeutics public capital or strategic-status source reviewed for stage and timeline signal.

Trust APublic review
Open source

Xaira Therapeutics official product profile

Xaira Therapeutics official site · official
Confidence A

Xaira Therapeutics official source reviewed for product scope, operating focus, and category placement.

Trust APublic review
Open source

Similar projects

Same category or overlapping tags